Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $213.1M | $212.7M | $195.2M | $44.5M | $50.1M | |
| Gross Profit | $161.2M | $161.4M | $140M | $32.5M | $34.8M | |
| Operating Income | $152.8M | $174.1M | $161.9M | $39M | $45.1M | |
| EBITDA | $152.8M | $174.1M | $161.9M | $39M | $45.1M | |
| Diluted EPS | $1.31 | $1.72 | $1.15 | $0.35 | $0.33 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $91.3M | $97.9M | $88.8M | $100.4M | $124.8M | |
| Total Assets | $2B | $2.1B | $2B | $1.8B | $2.6B | |
| Current Liabilities | $38M | $57.8M | $47M | $246.6M | $56.6M | |
| Total Liabilities | $1.1B | $1.1B | $1.1B | $910.3M | $1.4B | |
| Total Equity | $946M | $937.3M | $908.1M | $908.2M | $1.2B | |
| Total Debt | $1.1B | $1.1B | $1B | $848.5M | $1.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $72.1M | $82.9M | $117.4M | $20.9M | $13.7M | |
| Cash From Investing | $82.7M | $188.3M | -$279.8M | $42M | $20.1M | |
| Cash From Financing | -$168.2M | -$257.8M | $146M | -$86.4M | -$30.8M | |
| Free Cash Flow | $72.1M | $82.9M | $117.4M | $20.9M | $13.7M | |
Carlyle Secured Lending, Inc. is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Global Investment Solutions. The company was founded on February 2012, and is headquartered in New York, NY.
In the current month, CGBD has received 1 Buy ratings 5 Hold ratings, and 0 Sell ratings. The CGBD average analyst price target in the past 3 months is $13.36.
According to analysts, the consensus estimate is that Carlyle Secured Lending, share price will rise to $13.36 per share over the next 12 months.
Analysts are divided on their view about Carlyle Secured Lending, share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Carlyle Secured Lending, is a Sell and believe this share price will drop from its current level to $12.00.
The price target for Carlyle Secured Lending, over the next 1-year time period is forecast to be $13.36 according to 6 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Carlyle Secured Lending, is a Hold. 5 of 6 analysts rate the stock a Hold at this time.
You can purchase shares of Carlyle Secured Lending, via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Carlyle Secured Lending, shares.
Carlyle Secured Lending, was last trading at $12.54 per share. This represents the most recent stock quote for Carlyle Secured Lending,. Yesterday, Carlyle Secured Lending, closed at $12.55 per share.
In order to purchase Carlyle Secured Lending, stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.